Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawAbortion Drugs Issues in Law & Medicine

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

Additional authors: Calum Miller, MD and Kevin Duffy, MPH

 

Abstract

The U.S. FDA has permanently removed the in-person prescribing requirements that previously safeguarded the use of mifepristone/misoprostol medical abortions, allowing prescribing through telemedicine or on-line ordering and distribution through the mail and pharmacies, without standard pre-abortion testing. This will increase the risk of complications due to failure to adequately determine the gestational age or rule out ectopic pregnancy by ultrasound or physical exam, failure to perform labs to document whether RhoGAM is indicated, and failure to obtain appropriate informed consent to prevent unwanted abortions, among other concerns. The FDA justified this action by referencing flawed studies with significantly undercounted complications. The details of these study deficiencies are examined in this paper.

Read Complete Article

Latest Posts

November 16, 2026 Two cupped hands holding a small model of a human fetus. The new legal landscape after the abortion ballot initiatives November 9, 2026 Minimalist illustration of a small, flat-roofed building serving as a United States abortion center, featuring two windows and a central door. Fact Sheet: Gestational Breakdown of Brick-and-Mortar Abortion Centers in The United States October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

You Might Also Be Interested In

Two cupped hands holding a small model of a human fetus.

The new legal landscape after the abortion ballot initiatives

November 16, 2026
Minimalist illustration of a small, flat-roofed building serving as a United States abortion center, featuring two windows and a central door.

Fact Sheet: Gestational Breakdown of Brick-and-Mortar Abortion Centers in The United States

charlotte-lozier-institute Charlotte Lozier Institute
November 9, 2026
A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image